DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM
Welcome, future pharmacists and healthcare professionals!
As a pharmacy educator with years of experience teaching pharmaceutical chemistry, I have always emphasized that drugs acting on the autonomic nervous system (ANS) are among the most important and widely used classes of drugs in clinical practice. The autonomic nervous system controls involuntary body functions such as heart rate, respiration, digestion, glandular secretion, and smooth muscle activity. Drugs acting on this system modify these functions by stimulating or blocking nerve responses. Understanding these drugs is essential for pharmacy students to manage conditions such as hypertension, asthma, glaucoma, and many others.
In this comprehensive guide, I will take you through the classification, mechanisms of action, and therapeutic uses of drugs acting on the autonomic nervous system. We will explore sympathomimetic drugs (adrenergic agonists), adrenergic antagonists (sympatholytics), cholinergic drugs (parasympathomimetics), and cholinergic antagonists (parasympatholytics). By the end of this article, you will have a solid understanding of how these drugs work and their role in clinical practice. Let us begin.
THE AUTONOMIC NERVOUS SYSTEM: AN OVERVIEW
The autonomic nervous system is a division of the peripheral nervous system that regulates involuntary physiological functions. It has two main branches:
- Sympathetic Nervous System (SNS): Responsible for the “fight or flight” response. It increases heart rate, dilates pupils, and redirects blood flow to muscles.
- Parasympathetic Nervous System (PNS): Responsible for the “rest and digest” response. It decreases heart rate, stimulates digestion, and promotes relaxation.
Drugs acting on the ANS either stimulate (agonists) or block (antagonists) these responses, making them valuable in treating a wide range of conditions.
SYMPATHOMIMETIC DRUGS (ADRENERGIC AGONISTS)
Sympathomimetic drugs stimulate adrenergic receptors and mimic the action of epinephrine and norepinephrine. They may act directly on receptors or indirectly by releasing stored neurotransmitters. These drugs are used for their effects on the cardiovascular system, respiratory system, and central nervous system.
Classification Based on Use
- Vasoconstrictors: Norepinephrine, Metaraminol – used to increase blood pressure.
- Cardiac Stimulants: Dopamine, Dobutamine – used in heart failure and shock.
- CNS Stimulants: Amphetamine – used in narcolepsy and ADHD.
- Smooth Muscle Relaxants: Epinephrine, Isoprenaline – used in asthma and anaphylaxis.
- β2 Agonists: Salbutamol – used as bronchodilators in asthma.
- Anti-Allergic Agents: Epinephrine, Ephedrine – used in allergic reactions.
- Local Vasoconstrictors: Phenylephrine – used in nasal congestion.
- Appetite Suppressants: Phentermine – used in weight management.
Direct Acting Agents
Norepinephrine
Mechanism of Action: Norepinephrine is a potent α-agonist with some β1 activity. It causes vasoconstriction and increases blood pressure.
Therapeutic Uses: Used in severe hypotension and shock.
Side Effects: Hypertension, bradycardia, and tissue necrosis at injection site.
Epinephrine
Mechanism of Action: Epinephrine is a non-selective α and β agonist. It increases heart rate, bronchodilation, and vasoconstriction.
Therapeutic Uses: Used in anaphylaxis, cardiac arrest, asthma, and severe allergic reactions.
Side Effects: Tachycardia, hypertension, anxiety, and tremor.
Phenylephrine
Mechanism of Action: Phenylephrine is a selective α1 agonist that causes vasoconstriction.
Therapeutic Uses: Used as a nasal decongestant and to dilate the pupil.
Side Effects: Hypertension, reflex bradycardia, and headache.
Dopamine
Mechanism of Action: Dopamine is a precursor to norepinephrine and acts on dopamine, α, and β receptors.
Therapeutic Uses: Used in cardiogenic shock, heart failure, and sepsis.
Side Effects: Arrhythmias, nausea, and vasoconstriction.
Salbutamol (Albuterol)
Mechanism of Action: Salbutamol is a selective β2 agonist that causes bronchodilation.
Therapeutic Uses: Used in asthma and COPD.
Side Effects: Tremor, tachycardia, and palpitations.
Indirect Acting Agents
Indirect acting agents release stored norepinephrine from nerve endings, producing sympathomimetic effects.
Pseudoephedrine
Mechanism of Action: Pseudoephedrine releases norepinephrine from nerve endings.
Therapeutic Uses: Used as a nasal decongestant and mild bronchodilator.
Side Effects: Insomnia, nervousness, and hypertension.
Mixed Acting Agents
Mixed acting agents act directly on receptors and also release stored norepinephrine.
Ephedrine
Mechanism of Action: Ephedrine acts directly on α and β receptors and releases norepinephrine.
Therapeutic Uses: Used in asthma, hypotension, and allergic reactions.
Side Effects: Tachycardia, hypertension, and nervousness.
ADRENERGIC ANTAGONISTS (SYMPATHOLYTICS)
Adrenergic antagonists block adrenergic receptors and reduce sympathetic activity. They are classified into α-blockers and β-blockers based on their receptor selectivity.
α-Blockers
α-Blockers block α-adrenergic receptors, leading to vasodilation and reduced blood pressure.
- Prazosin: Used in hypertension and benign prostatic hyperplasia.
- Phentolamine: Used in pheochromocytoma and hypertensive emergencies.
β-Blockers
β-Blockers block β-adrenergic receptors, reducing heart rate and cardiac output.
Propranolol
Mechanism of Action: Propranolol is a non-selective β-blocker that reduces heart rate, cardiac output, and blood pressure.
Therapeutic Uses: Used in hypertension, arrhythmias, anxiety, migraine prophylaxis, and thyrotoxicosis.
Side Effects: Bradycardia, hypotension, bronchospasm, and fatigue.
CHOLINERGIC DRUGS (PARASYMPATHOMIMETICS)
Cholinergic drugs mimic the action of acetylcholine and stimulate muscarinic or nicotinic receptors. They are used to increase parasympathetic activity.
Pilocarpine
Mechanism of Action: Pilocarpine is a direct-acting muscarinic agonist.
Therapeutic Uses: Used in glaucoma to reduce intraocular pressure and in dry mouth (xerostomia).
Side Effects: Sweating, nausea, and bradycardia.
Neostigmine
Mechanism of Action: Neostigmine is an indirect-acting cholinergic agent that inhibits acetylcholinesterase, increasing acetylcholine levels.
Therapeutic Uses: Used in myasthenia gravis and reversal of neuromuscular blockade.
Side Effects: Bradycardia, nausea, and muscle twitching.
CHOLINERGIC ANTAGONISTS (PARASYMPATHOLYTICS)
Cholinergic antagonists block muscarinic receptors and reduce parasympathetic activity. They are used to relax smooth muscle and reduce secretions.
Atropine
Mechanism of Action: Atropine is a competitive antagonist at muscarinic receptors.
Therapeutic Uses: Used in bradycardia, pre-anesthesia, and as an antidote for organophosphate poisoning.
Side Effects: Dry mouth, blurred vision, and constipation.
Ipratropium
Mechanism of Action: Ipratropium is a short-acting muscarinic antagonist.
Therapeutic Uses: Used as a bronchodilator in COPD and asthma.
Side Effects: Dry mouth, cough, and headache.
Tropicamide
Mechanism of Action: Tropicamide is a short-acting muscarinic antagonist used for mydriasis.
Therapeutic Uses: Used to dilate the pupil for eye examinations.
Side Effects: Blurred vision and photophobia.
Dicyclomine
Mechanism of Action: Dicyclomine is a muscarinic antagonist used for smooth muscle relaxation.
Therapeutic Uses: Used in irritable bowel syndrome (IBS) and gastrointestinal spasms.
Side Effects: Dry mouth, dizziness, and blurred vision.
COMPARISON OF ANS DRUGS
| Drug Class | Example | Mechanism | Primary Use |
|---|---|---|---|
| Sympathomimetic | Ephedrine | α & β agonist | Asthma, hypotension |
| α-Blocker | Prazosin | α antagonist | Hypertension, BPH |
| β-Blocker | Propranolol | β antagonist | Hypertension, arrhythmia |
| Cholinergic Agonist | Pilocarpine | Muscarinic agonist | Glaucoma |
| Cholinergic Antagonist | Atropine | Muscarinic antagonist | Bradycardia, pre-anesthesia |
A TEACHER’S PRACTICAL INSIGHTS
Over my years of teaching, I have developed a few key insights about drugs acting on the autonomic nervous system that I always share with my students:
- Sympathomimetic drugs are powerful and can cause serious side effects such as hypertension and arrhythmias.
- β-blockers should be used cautiously in patients with asthma or COPD.
- Cholinergic drugs can cause bradycardia and increased secretions.
- Understanding receptor selectivity is essential for predicting drug effects and side effects.
FREQUENTLY ASKED QUESTIONS (FAQs)
1. What is the difference between sympathetic and parasympathetic nervous system?
The sympathetic nervous system prepares the body for “fight or flight,” while the parasympathetic nervous system promotes “rest and digest.”
2. What is the mechanism of action of ephedrine?
Ephedrine acts directly on α and β receptors and also releases norepinephrine from nerve endings.
3. What is the therapeutic use of propranolol?
Propranolol is used in hypertension, arrhythmias, anxiety, migraine prophylaxis, and thyrotoxicosis.
4. What is the mechanism of action of pilocarpine?
Pilocarpine is a direct-acting muscarinic agonist used to reduce intraocular pressure in glaucoma.
5. What is the therapeutic use of atropine?
Atropine is used in bradycardia, pre-anesthesia, and as an antidote for organophosphate poisoning.
6. What is the difference between α-blockers and β-blockers?
α-Blockers block α-adrenergic receptors, causing vasodilation. β-Blockers block β-adrenergic receptors, reducing heart rate and cardiac output.
7. What is ipratropium used for?
Ipratropium is a bronchodilator used in COPD and asthma.
SUMMARY
Drugs acting on the autonomic nervous system are essential for managing a wide range of conditions. Sympathomimetic drugs stimulate adrenergic receptors and are used in hypotension, asthma, and allergic reactions. Adrenergic antagonists block these receptors and are used in hypertension and arrhythmias. Cholinergic drugs mimic acetylcholine and are used in glaucoma and myasthenia gravis. Cholinergic antagonists block muscarinic receptors and are used in bradycardia, COPD, and gastrointestinal disorders.
Understanding these drugs is essential for pharmacy students to ensure their safe and effective use in clinical practice.
As I always tell my students: “The autonomic nervous system is the body’s automatic control system. Understanding its pharmacology is the key to managing many common conditions.”
REFERENCES & FURTHER READING
- Government of India. (1948). The Pharmacy Act, 1948. Ministry of Health and Family Welfare.
- Indian Pharmacopoeia Commission (IPC). (2023). Indian Pharmacopoeia. Retrieved from IPC Official Website.
- World Health Organization (WHO). (2023). WHO Model List of Essential Medicines. Retrieved from WHO Official Website.
- International Pharmaceutical Federation (FIP). (2023). Pharmacy Practice and Autonomic Pharmacology. Retrieved from FIP Official Website.
- American Society of Health-System Pharmacists (ASHP). (2023). Autonomic Nervous System Drug Guidelines. Retrieved from ASHP Official Website.
Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. Always consult qualified healthcare professionals and regulatory authorities for professional and legal matters.

Dr. Saint Paul is a pharmacy educator, Pharm.D graduate, and academic content creator from Jawaharlal Nehru Technological University Kakinada (JNTUK), where he completed his Doctor of Pharmacy (Pharm.D) degree between 2015 and 2021.
He has more than 7 years of experience creating pharmacy educational content, writing study materials, and reviewing academic articles for pharmacy students. He has also contributed guest articles to pharmacy education platforms, including PharmD Guru.
At D.PharmGuru, his work focuses on simplifying complex Diploma in Pharmacy (D.Pharmacy) subjects into easy-to-understand notes, practical explanations, and exam-oriented educational resources for students across India.
His areas of focus include Human Anatomy and Physiology, Pharmaceutics, Pharmacology, Pharmaceutical Chemistry, Hospital and Clinical Pharmacy, and other core D.Pharmacy subjects.



